Agenda : 25’ Results of the FAMHP IDMP gap analysis: 1. EMA : deviations (more, less, different) versus ISO IDMP documents (of 2012 and 2017, whichever is more recent) 2. FAMHP MPM/DTS : differences with the EMA data model 3. FAMHP approach to narrow the gaps 10’ QUESTIONS 15’ SAM / ePrescription : dataflow from BE […]
►You can register for the relevant Webinar by selecting the link below: SPOR and XEVMPD Data Governance - 17 April, 10:00-12:00 CET - https://ema-europa.webex.com/weblink/register/r9ca0c1044ed05282d0fe236251c99a9c Service Desk for SPOR and XEVMPD - 17 April, 14:00-16:00 CET - https://ema-europa.webex.com/weblink/register/r1552802c0646096c101b5e62b25dfa5d Referentials Management Service (RMS) - 18 April, 10:00-12:00 CET - https://ema-europa.webex.com/weblink/register/r46516995ff51d5f4383d95f05cac8e38 Organisation Management Service (OMS) - 18 April, 14:00-16:00 - https://ema-europa.webex.com/weblink/register/r834ea26426a57529292e0dcffc96cb5a Substance Management […]
Description: Referring to the landscape of medicinal product data – from “research and development” to “utilisation and outcome assessments”- the vision is that the essential IDMP identifiers remain used and unchanged along that life cycle. This Community of Expertise (CoE) will provide opportunity : for industry to present their perspective and needs, with large international […]
Central thema: Administrable products : Based on relationship between manufactured and administrable dose form, - NoMA's solution to meet needs in clinical practice. REGISTER
REGISTER NOW FOT THIS EVENT
You may already REGISTER
Unicom will be presenting all the results of WP2 related to SUBSTANCES
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
